Study group characteristics
| . | Males . | Females . | P . |
|---|---|---|---|
| tHcy, μM | 9.2 [4.4-44.6] | 8.6 [4.2-37.4] | .22 |
| (222) | (185) | ||
| Serum folate, nM | 12.6 [3.2-44.5] | 13.2 [4.7-213.0] | .24 |
| (194) | (164) | ||
| RCF, μg/L RBCs | 309 [79-1044] | 247 [61-1055] | < .001 |
| (193) | (177) | ||
| Vitamin B12, pM | 287 [104-1230] | 242 [19-491] | < .001 |
| (195) | (164) | ||
| Creatinine, μM | 73 [41-130] | 55 [22-93] | < .001 |
| (220) | (185) | ||
| Hormonal contraceptive use, % | Not applicable | 47.4 | — |
| Regular alcohol intake, % | 84.2 | 74.6 | .02* |
| . | Males . | Females . | P . |
|---|---|---|---|
| tHcy, μM | 9.2 [4.4-44.6] | 8.6 [4.2-37.4] | .22 |
| (222) | (185) | ||
| Serum folate, nM | 12.6 [3.2-44.5] | 13.2 [4.7-213.0] | .24 |
| (194) | (164) | ||
| RCF, μg/L RBCs | 309 [79-1044] | 247 [61-1055] | < .001 |
| (193) | (177) | ||
| Vitamin B12, pM | 287 [104-1230] | 242 [19-491] | < .001 |
| (195) | (164) | ||
| Creatinine, μM | 73 [41-130] | 55 [22-93] | < .001 |
| (220) | (185) | ||
| Hormonal contraceptive use, % | Not applicable | 47.4 | — |
| Regular alcohol intake, % | 84.2 | 74.6 | .02* |
Concentrations are expressed as median [minimum − maximum]. Number of individuals is indicated in parentheses. Differences in continuous variables between groups were assessed byt test on logarithmically-transformed data. tHcy indicates total plasma homocysteine; RCF, red cell folate.
Chi-squared analysis.